hemoglobinuria


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

he·mo·glo·bi·nu·ri·a

 (hē′mə-glō′bə-no͝o′ē-ə, -nyo͝or′-)
n.
The presence of hemoglobin in the urine.

he′mo·glo′bi·nu′ric adj.

he•mo•glo•bi•nu•ri•a

(ˌhi məˌgloʊ bəˈnʊər i ə, -ˈnyʊər-)

n.
the presence of hemoglobin pigment in the urine.
[1865–70]
he`mo•glo`bi•nu′ric, adj.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.hemoglobinuria - presence of hemoglobin in the urine
symptom - (medicine) any sensation or change in bodily function that is experienced by a patient and is associated with a particular disease
Translations

hemoglobinuria

n hemoglobinuria; paroxysmal nocturnal — hemoglobinuria paroxística nocturna
References in periodicals archive ?
The main focus of the study is on the diseases, mastitis, Parturient Hemoglobinuria, FMD, and tick infestation.
Pompano Beach, FL, February 06, 2015 --(PR.com)-- Access Health[R], a new magazine-style health and wellness series will dedicate an entire 30-minute episode to the rare blood disease PNH, which stands for Paroxysmal Nocturnal Hemoglobinuria, a rare and potentially life-threatening disease, on Wednesday, February 11 at 7:30 a.m.
Laboratory values included levels of bilirubin of 89 [micro]mol/L, lactate dehydrogenase (LDH) of 1,976 (reference 120-240) U/L, hemoglobin of 81 g/L and marked hemoglobinuria. Multiple thick and thin blood smears were negative for Plasmodium spp.
Dark brown urine can be caused by foods, medications, bilirubin, hematuria or hemoglobinuria, and myoglobinuria.
Soliris paroxysmal nocturnal hemoglobinuria (PNH) (Japan)
At age 19, Day was diagnosed with paroxysmal nocturnal hemoglobinuria, a rare blood disorder.
Food and Drug Administration (March 2007), the European Commission (June 2007), Health Canada (January 2009) and Australia's Therapeutic Goods Administration (February 2009) as the first treatment for all patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare, debilitating and life-threatening blood disorder defined by hemolysis, or the destruction of red blood cells.
Em 28 de janeiro todos os animais foram vacinados para hemoglobinuria bacilar por ser esta a primeira suspeita da causa da mortalidade dos bovinos.
In March 2007, the FDA granted marketing approval for Alexion's first product, Soliris (eculizumab), for all patients with paroxysmal nocturnal hemoglobinuria ("PNH"), a rare, debilitating and life-threatening blood disease.
(Cheshire CT) won approval for its Soliris medication for treating paroxysmal nocturnal hemoglobinuria, or PNH.
launch underway for ULTOMIRIS[TM] (ravulizumab-cwvz) in adults with paroxysmal nocturnal hemoglobinuria (PNH); EU and Japanese applications under review